ASX - By Stock
|
AVE |
Re:
Interview
|
|
Mike senior
|
31 |
6.2K |
8 |
25/01/21 |
25/01/21 |
ASX - By Stock
|
31
|
6.2K
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Approval received for final stage of NNZ-2591 clinical trial
|
|
Mike senior
|
22 |
15K |
6 |
19/11/20 |
19/11/20 |
ASX - By Stock
|
22
|
15K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Approval received for final stage of NNZ-2591 clinical trial
|
|
Mike senior
|
22 |
15K |
1 |
19/11/20 |
19/11/20 |
ASX - By Stock
|
22
|
15K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Approval received for final stage of NNZ-2591 clinical trial
|
|
Mike senior
|
22 |
15K |
0 |
19/11/20 |
19/11/20 |
ASX - By Stock
|
22
|
15K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Approval received for final stage of NNZ-2591 clinical trial
|
|
Mike senior
|
22 |
15K |
2 |
19/11/20 |
19/11/20 |
ASX - By Stock
|
22
|
15K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Phase 3 trial of trofinetide in Rett syndrome commences
|
|
Mike senior
|
47 |
28K |
31 |
03/11/19 |
03/11/19 |
ASX - By Stock
|
47
|
28K
|
31
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Changes to Leadership Team
|
|
Mike senior
|
17 |
7.2K |
6 |
14/04/19 |
14/04/19 |
ASX - By Stock
|
17
|
7.2K
|
6
|
|
ASX - By Stock
|
AVE |
Re:
Share Price After Award Decision
|
|
Mike senior
|
166 |
55K |
3 |
30/10/18 |
30/10/18 |
ASX - By Stock
|
166
|
55K
|
3
|
|
ASX - By Stock
|
AVE |
Re:
Share Price After Award Decision
|
|
Mike senior
|
166 |
55K |
8 |
29/10/18 |
29/10/18 |
ASX - By Stock
|
166
|
55K
|
8
|
|
ASX - By Stock
|
AVE |
Re:
Share Price After Award Decision
|
|
Mike senior
|
166 |
55K |
4 |
29/10/18 |
29/10/18 |
ASX - By Stock
|
166
|
55K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Release Today Neuren Valuation Estimate Raised
|
|
Mike senior
|
82 |
61K |
37 |
18/03/18 |
18/03/18 |
ASX - By Stock
|
82
|
61K
|
37
|
|
ASX - By Stock
|
AVE |
Re:
Considering the claims
|
|
Mike senior
|
89 |
35K |
4 |
21/01/18 |
21/01/18 |
ASX - By Stock
|
89
|
35K
|
4
|
|
ASX - By Stock
|
AVE |
Re:
Considering the claims
|
|
Mike senior
|
89 |
35K |
3 |
20/01/18 |
20/01/18 |
ASX - By Stock
|
89
|
35K
|
3
|
|
ASX - By Stock
|
AVE |
Re:
Ross The Boss
|
|
Mike senior
|
3 |
1.6K |
0 |
08/01/18 |
08/01/18 |
ASX - By Stock
|
3
|
1.6K
|
0
|
|
ASX - By Stock
|
AVE |
Re:
Ross The Boss
|
|
Mike senior
|
3 |
1.6K |
0 |
08/01/18 |
08/01/18 |
ASX - By Stock
|
3
|
1.6K
|
0
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Ceasing to be a substantial holder
|
|
Mike senior
|
63 |
22K |
7 |
06/01/18 |
06/01/18 |
ASX - By Stock
|
63
|
22K
|
7
|
|
ASX - By Stock
|
NEU |
Christmas Wonderland
|
|
Mike senior
|
10 |
8.0K |
115 |
21/12/17 |
21/12/17 |
ASX - By Stock
|
10
|
8.0K
|
115
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Phosphagenics Update on TPM/Propofol Development Program
|
|
Mike senior
|
26 |
7.8K |
14 |
09/11/17 |
09/11/17 |
ASX - By Stock
|
26
|
7.8K
|
14
|
|
ASX - By Stock
|
AVE |
Re:
Research Articles
|
|
Mike senior
|
49 |
10K |
19 |
04/11/17 |
04/11/17 |
ASX - By Stock
|
49
|
10K
|
19
|
|
ASX - By Stock
|
AVE |
Re:
cap raise closed
|
|
Mike senior
|
54 |
12K |
4 |
24/10/17 |
24/10/17 |
ASX - By Stock
|
54
|
12K
|
4
|
|
ASX - By Stock
|
AVE |
Re:
Research Articles
|
|
Mike senior
|
49 |
10K |
18 |
21/09/17 |
21/09/17 |
ASX - By Stock
|
49
|
10K
|
18
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Phosphagenics Market Update - Potential Return of Capital
|
|
Mike senior
|
171 |
48K |
3 |
09/09/17 |
09/09/17 |
ASX - By Stock
|
171
|
48K
|
3
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Phosphagenics Market Update - Potential Return of Capital
|
|
Mike senior
|
171 |
48K |
0 |
09/09/17 |
09/09/17 |
ASX - By Stock
|
171
|
48K
|
0
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Phosphagenics Market Update - Potential Return of Capital
|
|
Mike senior
|
171 |
48K |
0 |
08/09/17 |
08/09/17 |
ASX - By Stock
|
171
|
48K
|
0
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Phosphagenics Market Update - Potential Return of Capital
|
|
Mike senior
|
171 |
48K |
9 |
08/09/17 |
08/09/17 |
ASX - By Stock
|
171
|
48K
|
9
|
|
ASX - By Stock
|
NEU |
Re:
BP update
|
|
Mike senior
|
13 |
12K |
82 |
04/09/17 |
04/09/17 |
ASX - By Stock
|
13
|
12K
|
82
|
|
ASX - By Stock
|
AVE |
Re:
Oxymorphone Peer Reviewed Journal
|
|
Mike senior
|
36 |
7.2K |
8 |
20/08/17 |
20/08/17 |
ASX - By Stock
|
36
|
7.2K
|
8
|
|
ASX - By Stock
|
AVE |
Oxymorphone Peer Reviewed Journal
|
|
Mike senior
|
36 |
7.2K |
9 |
20/08/17 |
20/08/17 |
ASX - By Stock
|
36
|
7.2K
|
9
|
|
ASX - By Stock
|
AVE |
Re:
Terumo
|
|
Mike senior
|
20 |
4.8K |
9 |
16/08/17 |
16/08/17 |
ASX - By Stock
|
20
|
4.8K
|
9
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Phosphagenics Sells BioElixia Brand to Pure Beauty Australia
|
|
Mike senior
|
58 |
17K |
6 |
13/08/17 |
13/08/17 |
ASX - By Stock
|
58
|
17K
|
6
|
|
ASX - By Stock
|
AVE |
Re:
Research Articles
|
|
Mike senior
|
49 |
10K |
11 |
04/08/17 |
04/08/17 |
ASX - By Stock
|
49
|
10K
|
11
|
|
ASX - By Stock
|
AVE |
Re:
Terumo and Propofol Injectable
|
|
Mike senior
|
133 |
46K |
15 |
19/06/17 |
19/06/17 |
ASX - By Stock
|
133
|
46K
|
15
|
|
ASX - By Stock
|
AVE |
Themis Medicare JV
|
|
Mike senior
|
0 |
595 |
14 |
23/04/17 |
23/04/17 |
ASX - By Stock
|
0
|
595
|
14
|
|
ASX - By Stock
|
AVE |
Research Articles
|
|
Mike senior
|
49 |
10K |
7 |
22/04/17 |
22/04/17 |
ASX - By Stock
|
49
|
10K
|
7
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Phosphagenics and IAH Cease All Partnerships
|
|
Mike senior
|
42 |
14K |
1 |
09/03/17 |
09/03/17 |
ASX - By Stock
|
42
|
14K
|
1
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Phosphagenics and IAH Cease All Partnerships
|
|
Mike senior
|
42 |
14K |
13 |
09/03/17 |
09/03/17 |
ASX - By Stock
|
42
|
14K
|
13
|
|
ASX - By Stock
|
AVE |
Mastitis Patent Granted
|
|
Mike senior
|
2 |
1.1K |
15 |
09/02/17 |
09/02/17 |
ASX - By Stock
|
2
|
1.1K
|
15
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Phosphagenics December Newsletter
|
|
Mike senior
|
57 |
14K |
16 |
02/01/17 |
02/01/17 |
ASX - By Stock
|
57
|
14K
|
16
|
|
ASX - By Stock
|
AVE |
Re:
Carrier Composition New Patent
|
|
Mike senior
|
5 |
2.0K |
3 |
19/11/16 |
19/11/16 |
ASX - By Stock
|
5
|
2.0K
|
3
|
|
ASX - By Stock
|
AVE |
Carrier Composition New Patent
|
|
Mike senior
|
5 |
2.0K |
13 |
19/11/16 |
19/11/16 |
ASX - By Stock
|
5
|
2.0K
|
13
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Phosphagenics ProPhase Arbitration Ruling Handed Down
|
|
Mike senior
|
120 |
30K |
6 |
16/11/16 |
16/11/16 |
ASX - By Stock
|
120
|
30K
|
6
|
|
ASX - By Stock
|
AVE |
Drug Delivery and Translational Research
|
|
Mike senior
|
0 |
696 |
17 |
02/10/16 |
02/10/16 |
ASX - By Stock
|
0
|
696
|
17
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Phosphagenics Initiates Arbitration Against Mylan
|
|
Mike senior
|
305 |
71K |
7 |
06/04/16 |
06/04/16 |
ASX - By Stock
|
305
|
71K
|
7
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Phosphagenics Initiates Arbitration Against Mylan
|
|
Mike senior
|
305 |
71K |
10 |
05/04/16 |
05/04/16 |
ASX - By Stock
|
305
|
71K
|
10
|
|
ASX - By Stock
|
AVE |
Re:
Voveran TPM Gel
|
|
Mike senior
|
12 |
4.2K |
1 |
03/01/16 |
03/01/16 |
ASX - By Stock
|
12
|
4.2K
|
1
|
|
ASX - By Stock
|
AVE |
Re:
New all time low
|
|
Mike senior
|
71 |
17K |
6 |
30/12/15 |
30/12/15 |
ASX - By Stock
|
71
|
17K
|
6
|
|
ASX - By Stock
|
AVE |
Re:
New all time low
|
|
Mike senior
|
71 |
17K |
5 |
30/12/15 |
30/12/15 |
ASX - By Stock
|
71
|
17K
|
5
|
|
ASX - By Stock
|
AVE |
Re:
What's with the piglets?
|
|
Mike senior
|
42 |
10K |
7 |
04/12/15 |
04/12/15 |
ASX - By Stock
|
42
|
10K
|
7
|
|
ASX - By Stock
|
AVE |
Re:
What's with the piglets?
|
|
Mike senior
|
42 |
10K |
6 |
04/12/15 |
04/12/15 |
ASX - By Stock
|
42
|
10K
|
6
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Quarterly Shareholder Update teleconference
|
|
Mike senior
|
11 |
2.9K |
2 |
23/10/15 |
23/10/15 |
ASX - By Stock
|
11
|
2.9K
|
2
|
|